Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Gastroenterology

• Publication date

  2016-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.gastro.2016.06.021PMID 27342213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study

  2016cited by this paper
• Common bile duct diameter in an asymptomatic population: A magnetic resonance imaging study.

  2015cited by this paper
• Appearance of hepatobiliary diseases in a population‐based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region)

  2015cited by this paper
• gender and Ibd phenotype are independent predictors of death or transplantation and of malignancy in Primary Sclerosing Cholangitis - a multicenter retrospective study of the International Psc Study Group (ipscsg) : 76

  2015cited by this paper
• Ultrasound Measurements of the Bile Ducts and Gallbladder: Normal Ranges and Effects of Age, Sex, Cholecystectomy, and Pathologic States

  2014cited by this paper
• Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis.

  2014cited by this paper
• Radiologic course of primary sclerosing cholangitis: Assessment by three‐dimensional magnetic resonance cholangiography and predictive features of progression

  2014cited by this paper
• Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis.

  2013cited by this paper
• Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

  2013cited by this paper
• Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study

  2013cited by this paper
• Investigative MR Cholangiopancreatography for Primary Sclerosing Cholangitis–type Lesions in Children With IBD

  2012cited by this paper
• Does screening for subclinical PSC contribute to the management of IBD?

  2012cited by this paper
• Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease

  2011cited by this paper
• Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography.

  2010cited by this paper
• Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

  2009cited by this paper
• Common disorders are quantitative traits

  2009cited by this paper
• Predictive Value of Serologic Markers in a Population‐based Norwegian Cohort with Inflammatory Bowel Disease

  2009cited by this paper
• Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study.

  2007cited by this paper
• Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer

  2006cited by this paper
• PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

  2004cited by this paper
• Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis

  2004cited by this paper
• Primary sclerosing cholangitis

  2001cited by this paper
• The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study

  2001cited by this paper
• Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease in Turkey

  2001cited by this paper
• Primary sclerosing cholangitis: evaluation with MR cholangiography-a case-control study.

  2000cited by this paper
• Primary sclerosing cholangitis: MR imaging features.

  1999cited by this paper
• Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.

  1996cited by this paper
• Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists.

  1995cited by this paper
• Incidence of Inflammatory Bowel Disease in Southeastern Norway: Evaluation of Methods after 1 Year of Registration

  1995cited by this paper
• Bias, prevalence and kappa.

  1993cited by this paper
• Relationship of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

  1991cited by this paper
• Primary sclerosing cholangitis : an important and prevalent complication of Crohn's disease

  1991cited by this paper
• Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease.

  1991cited by this paper
• Primary sclerosing cholangitis: a long-term follow-up study.

  1987cited by this paper
• Primary sclerosing cholangitis associated with inflammatory bowel disease in Cape Town, 1975 - 1981.

  1983cited by this paper
• Sclerosing cholangitis in ulcerative colitis. A follow-up study.

  1982cited by this paper

• Clinical Outcomes in Patients with Primary Sclerosing Cholangitis With and Without Inflammatory Bowel Disease.

  2026cites this paper
• Understanding hepatopancreatobiliary cancer risks in a population-based primary sclerosing cholangitis-inflammatory bowel disease cohort.

  2026cites this paper
• The Inflammatory Bowel Disease in South-Eastern Norway study: three decades of advancements in clinical understanding and scientific partnerships

  2026cites this paper
• Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward.

  2026cites this paper
• HERACLIS-PSC: Current characteristics of primary sclerosing cholangitis with or without inflammatory bowel disease in Greece-a national multicenter cohort study.

  2026cites this paper
• Prevalence and Bidirectional Association Between Primary Sclerosing Cholangitis and Crohn's disease: A Systematic Review and Meta-Analysis.

  2025cites this paper
• S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

  2025cites this paper
• The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids

  2025cites this paper
• PSC and colitis: A complex relationship.

  2025cites this paper
• Epidemiological and economical burden of cholestatic liver disease.

  2025cites this paper
• Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence‐based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation

  2025cites this paper
• Current challenges and prospects of magnetic resonance cholangiopancreatography: problems in clinical practice and theoretical approaches to their solution: a review

  2025cites this paper
• Primary Sclerosing Cholangitis Worsens Prognosis in Patients With Inflammatory Bowel Disease: A Propensity‐Matched Cohort Study

  2025cites this paper
• Primary sclerosing cholangitis–inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequence

  2024cites this paper
• Hepatic immune regulation and sex disparities

  2024cites this paper
• Sclerosing cholangitis and inflammatory bowel disease: a paradoxical relationship?

  2024cites this paper
• Identifying a therapeutic window of opportunity for people living with primary sclerosing cholangitis: Embryology and the overlap of inflammatory bowel disease with immune mediated liver injury.

  2024cites this paper
• Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study

  2024influential citation
• Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship.

  2024cites this paper
• Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval.

  2024cites this paper
• Case Report: Combined Autoimmune Pancreatitis, Ulcerative Colitis and Sclerosing Cholangitis in 28-y.o. Patient

  2024cites this paper
• The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)

  2024cites this paper
• Phospholipid complex-based microemulsion for treating concurrence of primary sclerosing cholangitis and inflammatory bowel disease via gut-liver crosstalk

  2024cites this paper
• Risk of comorbidity of autoimmune liver disease in patients with inflammatory bowel disease: A single‐center case–control study in China

  2024cites this paper
• Medical treatment of primary sclerosing cholangitis: What have we learned and where are we going?

  2024cites this paper
• Colectomy in patients with ulcerative colitis is not associated to future diagnosis of primary sclerosing cholangitis

  2023cites this paper
• ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.

  2023cites this paper
• Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

  2023cites this paper
• Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis

  2023cites this paper
• Incidence of cancer in patients with ulcerative colitis 30 years after diagnosis (the IBSEN study)

  2023cites this paper
• Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease

  2023cites this paper
• Recent Advances in the Management of Primary Sclerosing Cholangitis.

  2023cites this paper
• Geschlechtsspezifische Unterschiede in gastroenterologischen Erkrankungen

  2023cites this paper
• Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis

  2023cites this paper
• Global burden of Liver Disease: 2023 Update.

  2023cites this paper
• NOTCH signalling – a core regulator of bile duct disease?

  2023cites this paper
• Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?

  2023cites this paper
• Practical approach to abnormal liver enzymes in patients with inflammatory bowel disease

  2023cites this paper
• Prevalence of hepatobiliary manifestations in inflammatory bowel disease: a GRADE assessed systematic review and meta-analysis on more than 1.7 million patients.

  2023cites this paper
• Microbial exposure during early life regulates development of bile duct inflammation

  2023cites this paper
• Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study

  2023cites this paper
• Whole blood RNA sequencing identifies transcriptional differences between primary sclerosing cholangitis and ulcerative colitis

  2023cites this paper
• Concurrent inflammatory bowel disease and primary sclerosing cholangitis: a review of pre- and post-transplant outcomes and treatment options

  2023cites this paper
• D-amino Acids Ameliorate Experimental Colitis and Cholangitis by Inhibiting Growth of Proteobacteria: Potential Therapeutic Role in Inflammatory Bowel Disease

  2023cites this paper
• Diagnostic Tests in Primary Sclerosing Cholangitis: Serology, Elastography, Imaging, and Histology.

  2023cites this paper
• Does colectomy in UC patients impact on the PSC onset?: A national registry brings new insights

  2023cites this paper
• Sclerosing cholangitis in children with inflammatory bowel disease

  2023influential citation
• Phenotypes of Primary Sclerosing Cholangitis and Differential Diagnosis.

  2023cites this paper
• Hepatobiliary manifestations in inflammatory bowel disease: A practical approach

  2022cites this paper
• Small duct primary sclerosing cholangitis: A discrete variant or a bridge to large duct disease, a practical review

  2022cites this paper
• Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India

  2022cites this paper
• PSC associated inflammatory bowel disease: a distinct entity

  2022cites this paper
• Choosing the right biologic for complications of inflammatory bowel disease

  2022cites this paper
• Manifestations hépatiques et biliaires des maladies inflammatoires chroniques des intestins

  2022cites this paper
• Primary sclerosing cholangitis—A long night's journey into day

  2022cites this paper
• AASLD Practice Guidance on Primary Sclerosing Cholangitis and Cholangiocarcinoma.

  2022cites this paper
• Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation

  2022cites this paper
• The microbiota and the gut–liver axis in primary sclerosing cholangitis

  2022cites this paper
• Association of autoimmune hepatobiliary pathology with inflammatory bowel diseases in children

  2022cites this paper
• Risk of hepato‐pancreato‐biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population‐based cohort study

  2022cites this paper
• AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis

  2022cites this paper
• Liver biopsy in inflammatory bowel disease patients with sustained abnormal liver function tests: a retrospective single-center study

  2022cites this paper
• Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions

  2021cites this paper
• Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta‐analysis

  2021cites this paper
• Liver involvement in inflammatory bowel disease: What should the clinician know?

  2021cites this paper
• Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population

  2021cites this paper
• Defining Primary Sclerosing Cholangitis: Results from an International PSC Study Group consensus process.

  2021cites this paper
• Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases

  2021cites this paper
• Primary schlerosing cholangitis in children with inflammatory bowel disease

  2021cites this paper
• Prevalence of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

  2021cites this paper
• The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies

  2021cites this paper
• Enfermedad de Crohn con compromiso extenso y manifestaciones extradigestivas inusuales: a propósito de un caso

  2021cites this paper
• Epidemiology, natural history and outcomes of primary sclerosing cholangitis: A systematic review of population-based studies.

  2021cites this paper
• Sclerosing cholangitis and inflammatory bowel disease: which comes first?

  2021cites this paper
• Feeding the gut-liver axis in PSC, what makes it different from IBD?

  2021cites this paper
• The characteristics of pediatric ulcerative colitis with primary sclerosing cholangitis: A single-center study in Taiwan.

  2021cites this paper
• The role of natural killer cells in liver inflammation

  2021cites this paper
• Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases

  2021cites this paper
• Crohn’s disease with extensive involvement and rare extraintestinal manifestations: A case report

  2021influential citation
• Primary sclerosing cholangitis.

  2021cites this paper
• Diagnosis of Primary Sclerosing Cholangitis Beyond Childhood is Associated with Worse Outcomes.

  2021cites this paper
• Hepatobiliary phenotype of individuals with chronic intestinal disorders

  2021cites this paper
• Primär sklerosierende Cholangitis

  2020cites this paper
• Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis

  2020cites this paper
• Sclerosing Cholangitis

  2020cites this paper
• Liver Disorders in Inflammatory Bowel Disease

  2020cites this paper
• RESULTS OF ACUTE PURULENT CHOLANGITIS TREATMENT WITH GENETIC ENGINEERING ANALOGUE OF DORNAZE-ALPHA NATURAL ENZYME.

  2020cites this paper
• Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases

  2020cites this paper
• Confounding and bias in observational studies in inflammatory bowel disease: a meta‐epidemiological study

  2020cites this paper
• Impact of Preexisting Inflammatory Bowel Disease on the Outcome of Liver Transplantation for Primary Sclerosing Cholangitis

  2020influential citation
• The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival

  2020cites this paper
• Gut microbiome in primary sclerosing cholangitis: A review

  2020cites this paper
• Clinical features and MRI progression of small duct primary sclerosing cholangitis (PSC).

  2020cites this paper
• Primary Sclerosing Cholangitis

  2020cites this paper
• Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Diseases, Based on Sex, Race, and Age.

  2020cites this paper
• Guideline review: British Society of Gastroenterology/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis

  2020cites this paper
• Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study

  2020cites this paper
• Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis

  2020cites this paper
• Inflammatory Bowel Disease-associated GP2 Autoantibodies Inhibit Mucosal Immune Response to Adherent-invasive Bacteria.

  2020cites this paper
• Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland

  2020cites this paper